Literature DB >> 28455541

Review of management and morbidity of pediatric craniopharyngioma patients in a low-middle-income country: a 12-year experience.

Nisreen Amayiri1, Maisa Swaidan2, Yocoub Yousef3, Hadeel Halalsheh4, Ramiz Abu-Hijlih5, Sima Kalaldeh4, Maha Barbar4,6, Maher Elayyan3, Nesreen Faqih4, Maysa Al-Hussaini7, Mustafa Mehyar3, Ute Bartels8, James Drake9, Awni Musharbash3, Eric Bouffet8.   

Abstract

BACKGROUND: Management of craniopharyngioma in children is challenging, and their quality of life can be significantly affected. Series describing this from low-middle income countries (LMIC) are few. PATIENTS AND METHODS: The study provides a retrospective chart review of pediatric patients <18 years old, diagnosed with craniopharyngioma between 2003 and 2014, and treated at King Hussein Cancer Center, Jordan.
RESULTS: Twenty-four patients (12 males) were identified. Median age at diagnosis was 7.4 years (0.9-16.4 years). Commonest symptoms were visual impairment and headache (71%). Review of seventeen preoperative MRIs showed hypothalamic involvement in 88% and hydrocephalus in 76%. Thirteen patients (54%) had multiple surgical interventions. Five patients (21%) had initial gross total resection. Eleven patients (46%) received radiotherapy and six (25%) intra-cystic interferon. Five years' survival was 87 ± 7% with a median follow-up of 4.5 years (0.3-12.3 years). Four patients (17%) died; one after post-operative cerebral infarction and three secondary to hypothalamic damage. At their last evaluation, all but one patient required multiple hormonal supplements. Ten patients (42%) had best eye visual acuity (VA) >20/40, and four (16%) were legally blind. Eleven patients (46%) were overweight/obese; one had gastric bypass surgery. Seven patients had hyperlipidemia, and eight developed fatty liver infiltration. Eleven patients (65%) were attending schools and one at college. Nine of the living patients (53%) expressed difficulty to engage in the community.
CONCLUSIONS: Management of pediatric craniopharyngioma is particularly complex and demanding in LMIC. Multidisciplinary care is integral to optimize the care and minimize the morbidities. A management outline for LMIC is proposed.

Entities:  

Keywords:  Craniopharyngioma; Low middle income country; Multidisciplinary care

Mesh:

Year:  2017        PMID: 28455541     DOI: 10.1007/s00381-017-3411-4

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  29 in total

1.  Early adjuvant radiotherapy toward long-term survival and better quality of life for craniopharyngiomas--a study in single institute.

Authors:  Sung Ho Moon; Il Han Kim; Seok Won Park; Inah Kim; Semie Hong; Charn Il Park; Kyu Chang Wang; Byung Kyu Cho
Journal:  Childs Nerv Syst       Date:  2005-06-14       Impact factor: 1.475

2.  Pediatric craniopharyngioma--rationale for multimodal management: the Egyptian experience.

Authors:  Mohamed A Hafez; Sherif ElMekkawy; Hazem AbdelBadie; Mohamed Mohy; Mohamed Omar
Journal:  J Pediatr Endocrinol Metab       Date:  2006-04       Impact factor: 1.634

3.  Recurrence in pediatric craniopharyngiomas: analysis of clinical and histological features.

Authors:  Deepak Kumar Gupta; B K Ojha; Chitra Sarkar; Ashok Kumar Mahapatra; B S Sharma; V S Mehta
Journal:  Childs Nerv Syst       Date:  2005-05-14       Impact factor: 1.475

Review 4.  Childhood craniopharyngioma.

Authors:  Hermann L Müller
Journal:  Pituitary       Date:  2013-03       Impact factor: 4.107

5.  Longitudinal investigation of adaptive functioning following conformal irradiation for pediatric craniopharyngioma and low-grade glioma.

Authors:  Kelli L Netson; Heather M Conklin; Shengjie Wu; Xiaoping Xiong; Thomas E Merchant
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-12-11       Impact factor: 7.038

6.  Trends in treatment and outcomes of pediatric craniopharyngioma, 1975-2011.

Authors:  Michal Cohen; Ute Bartels; Helen Branson; Abhaya V Kulkarni; Jill Hamilton
Journal:  Neuro Oncol       Date:  2013-03-13       Impact factor: 12.300

7.  Clinical outcome in children with craniopharyngioma treated with primary surgery and radiotherapy deferred until relapse.

Authors:  John A Kalapurakal; Stewart Goldman; Y C Hsieh; Tadanori Tomita; Maryanne H Marymont
Journal:  Med Pediatr Oncol       Date:  2003-04

8.  Radical resection of 202 pediatric craniopharyngiomas with special reference to the surgical approaches and hypothalamic protection.

Authors:  Yu Qi Zhang; Zhen Yu Ma; Zhe Bao Wu; Shi Qi Luo; Zhong Cheng Wang
Journal:  Pediatr Neurosurg       Date:  2008-11-17       Impact factor: 1.162

9.  Quality of Life and Clinical Features of Long-Term Survivors Surgically Treated for Pediatric Craniopharyngioma.

Authors:  Shigetoshi Yano; Mareina Kudo; Takuichiro Hide; Naoki Shinojima; Keishi Makino; Hideo Nakamura; Jun-Ichi Kuratsu
Journal:  World Neurosurg       Date:  2015-09-01       Impact factor: 2.104

10.  Intracystic therapies for cystic craniopharyngioma in childhood.

Authors:  Ute Bartels; Normand Laperriere; Eric Bouffet; James Drake
Journal:  Front Endocrinol (Lausanne)       Date:  2012-03-27       Impact factor: 5.555

View more
  3 in total

Review 1.  Hypothalamic syndrome.

Authors:  Hermann L Müller; Maithé Tauber; Elizabeth A Lawson; Jale Özyurt; Brigitte Bison; Juan-Pedro Martinez-Barbera; Stephanie Puget; Thomas E Merchant; Hanneke M van Santen
Journal:  Nat Rev Dis Primers       Date:  2022-04-21       Impact factor: 52.329

2.  Improving Pediatric Neuro-Oncology Survival Disparities in the United States-Mexico Border Region: A Cross-Border Initiative Between San Diego, California, and Tijuana, Mexico.

Authors:  Paula Aristizabal; Luke P Burns; Nikhil V Kumar; Bianca P Perdomo; Rebeca Rivera-Gomez; Mario A Ornelas; David Gonda; Denise Malicki; Courtney D Thornburg; William Roberts; Michael L Levy; John R Crawford
Journal:  JCO Glob Oncol       Date:  2020-11

3.  Successful Diagnoses and Remarkable Metabolic Disorders in Patients With Solitary Hypothalamic Mass: A Case Series Report.

Authors:  Boni Xiang; Quanya Sun; Min He; Wei Wu; Bin Lu; Shuo Zhang; Zhaoyun Zhang; Yehong Yang; Yiming Li; Yue Wu; Zhenwei Yao; Haixia Cheng; Li Pan; Qing Miao; Yongfei Wang; Hongying Ye
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-16       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.